Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
ESTA

ESTA - Establishment Labs Holdings Inc Stock Price, Fair Value and News

43.50USD+0.29 (+0.67%)Market Closed

Market Summary

ESTA
USD43.50+0.29
Market Closed
0.67%

ESTA Alerts

  • Big fall in Revenue (Y/Y)
  • Big fall in earnings (Y/Y)
  • Losses in recent quarter

ESTA Stock Price

View Fullscreen

ESTA RSI Chart

ESTA Valuation

Market Cap

1.2B

Price/Earnings (Trailing)

-14.46

Price/Sales (Trailing)

7.68

EV/EBITDA

-19.58

Price/Free Cashflow

-13.32

ESTA Price/Sales (Trailing)

ESTA Profitability

Operating Margin

65.01%

EBT Margin

-53.43%

Return on Equity

-145.42%

Return on Assets

-27.42%

Free Cashflow Yield

-7.51%

ESTA Fundamentals

ESTA Revenue

Revenue (TTM)

155.8M

Rev. Growth (Yr)

-20.11%

Rev. Growth (Qtr)

17.77%

ESTA Earnings

Earnings (TTM)

-82.8M

Earnings Growth (Yr)

-35.67%

Earnings Growth (Qtr)

21.13%

Breaking Down ESTA Revenue

Last 7 days

-6.6%

Last 30 days

-23.1%

Last 90 days

-14.8%

Trailing 12 Months

-33.3%

How does ESTA drawdown profile look like?

ESTA Financial Health

Current Ratio

4.24

Debt/Equity

3.38

Debt/Cashflow

-0.41

ESTA Investor Care

Shares Dilution (1Y)

6.90%

Diluted EPS (TTM)

-3.16

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024155.8M000
2023169.8M177.1M177.4M165.2M
2022134.8M144.0M153.2M161.7M
202190.5M112.1M118.3M126.7M
202093.3M82.1M82.0M84.7M
201967.2M75.1M81.7M89.6M
201841.3M47.9M54.6M61.2M
201700034.7M

Tracking the Latest Insider Buys and Sells of Establishment Labs Holdings Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
May 24, 2024
condon dennis e
acquired
-
-
2,334
-
May 24, 2024
schutter edward j
acquired
-
-
2,334
-
May 24, 2024
custin ann
acquired
-
-
2,334
-
May 24, 2024
gillin leslie
acquired
-
-
2,334
-
May 24, 2024
slotkin bryan
acquired
-
-
2,334
-
May 24, 2024
lewin nicholas sheridan
acquired
-
-
2,334
-
Apr 10, 2024
denhoy raj
sold (taxes)
-16,701
53.19
-314
chief financial officer
Mar 31, 2024
schutter edward j
acquired
18,731
50.9
368
-
Mar 31, 2024
slotkin bryan
acquired
16,237
50.9
319
-
Mar 31, 2024
condon dennis e
acquired
14,964
50.9
294
-

1–10 of 50

Which funds bought or sold ESTA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 22, 2024
BigSur Wealth Management LLC
reduced
-14.84
594,108
1,475,210
0.46%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
added
14.52
483,674
870,186
-%
May 16, 2024
JANE STREET GROUP, LLC
reduced
-19.83
413,680
1,131,610
-%
May 15, 2024
Nantahala Capital Management, LLC
reduced
-60.23
-27,908,400
99,996,200
5.71%
May 15, 2024
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
sold off
-100
-2,977
-
-%
May 15, 2024
TWO SIGMA INVESTMENTS, LP
sold off
-100
-914,590
-
-%
May 15, 2024
Point72 Asset Management, L.P.
new
-
29,052,200
29,052,200
0.07%
May 15, 2024
PERCEPTIVE ADVISORS LLC
unchanged
-
2,058,300
4,189,020
0.07%
May 15, 2024
MILLENNIUM MANAGEMENT LLC
added
16.62
4,955,270
8,788,500
-%
May 15, 2024
Schonfeld Strategic Advisors LLC
new
-
323,724
323,724
-%

1–10 of 37

Are Funds Buying or Selling ESTA?

Are funds buying ESTA calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own ESTA
No. of Funds

Unveiling Establishment Labs Holdings Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
rtw investments, lp
9.7%
2,494,138
SC 13G/A
Feb 14, 2024
nantahala capital management, llc
9.5%
2,470,154
SC 13G/A
Feb 09, 2024
chacon quiros juan jose
5.6%
1,439,943
SC 13G
Feb 09, 2024
brown advisory inc
9.3%
2,398,166
SC 13G/A
Feb 14, 2023
pura vida investments, llc
4.12%
1,002,767
SC 13G/A
Feb 14, 2023
rtw investments, lp
9.8%
2,374,138
SC 13G/A
Feb 14, 2023
nantahala capital management, llc
7.9%
1,915,023
SC 13G/A
Feb 09, 2023
brown advisory inc
6%
1,463,998
SC 13G/A
Jan 20, 2023
chacon quiros juan jose
5.8%
1,401,132
SC 13G/A
Feb 14, 2022
pura vida investments, llc
5.50%
1,319,398
SC 13G/A

Recent SEC filings of Establishment Labs Holdings Inc

View All Filings
Date Filed Form Type Document
Jun 05, 2024
8-K
Current Report
May 28, 2024
4
Insider Trading
May 28, 2024
4
Insider Trading
May 28, 2024
4
Insider Trading
May 28, 2024
4
Insider Trading
May 28, 2024
4
Insider Trading
May 28, 2024
4
Insider Trading
May 28, 2024
8-K
Current Report
May 09, 2024
10-Q
Quarterly Report
May 08, 2024
8-K
Current Report

Peers (Alternatives to Establishment Labs Holdings Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
181.0B
40.3B
-0.10% -2.08%
32.14
4.49
-2.84% -3.00%
67.6B
19.7B
-1.04% -9.58%
50.7
3.43
4.82% -17.56%
18.2B
3.9B
-10.79% -26.67%
39.44
4.66
5.72% 46.72%
17.2B
14.9B
-4.26% -25.60%
6.49
1.15
2.98% 207.68%
MID-CAP
9.7B
3.5B
-0.60% 25.29%
31.07
2.74
6.16% 35.06%
8.7B
12.4B
-8.47% -12.48%
22.53
0.7
-0.93% -18.83%
8.2B
2.6B
-1.69% -23.28%
-25.56
3.16
-6.25% -68.58%
5.3B
3.9B
-9.26% -35.41%
-55.79
1.35
0.23% 90.80%
3.4B
387.1M
-0.06% 30.91%
-216.17
8.9
30.82% 65.57%
2.2B
6.6B
-1.48% -10.95%
12.01
0.34
1.50% -10.29%
SMALL-CAP
1.5B
3.2B
12.63% 11.29%
-2.15
0.46
7.94% -1695.32%
384.5M
169.3M
2.09% -2.41%
-5
2.27
7.49% -244.90%
226.3M
324.0M
-6.46% -49.01%
-1.18
0.7
-3.19% -337.41%
47.1M
50.5M
-15.62% -80.60%
-2.07
0.93
14.25% -10.06%
1.8M
3.7M
70.00% -81.62%
-0.15
0.48
5.77% 8.23%

Establishment Labs Holdings Inc News

Latest updates
The Globe and Mail17 Jun 202411:39 am
MarketBeat13 Jun 202409:31 pm
The Motley Fool7 months ago

Establishment Labs Holdings Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue17.8%37,167,00031,560,00038,506,00048,561,00046,524,00043,813,00038,245,00041,190,00038,452,00035,313,00029,039,00031,994,00030,336,00026,963,00022,758,00010,474,00024,481,00024,249,00022,854,00021,684,00020,778,000
Cost Of Revenue16.5%12,787,00010,975,00012,454,00018,300,00016,445,00015,648,00012,205,00013,736,00013,516,00011,087,0009,419,00010,526,00010,246,00012,319,0007,612,0003,240,0009,003,0007,890,0008,616,0008,672,0009,526,000
Gross Profit18.4%24,380,00020,585,00026,052,00030,261,00030,079,00028,165,00026,040,00027,454,00024,936,00024,226,00019,620,00021,468,00020,090,00014,644,00015,146,0007,234,00015,478,00016,359,00014,238,00013,012,00011,252,000
Operating Expenses-22.2%33,214,00042,700,00047,090,00043,974,00038,239,00041,325,00036,557,00037,860,00030,511,00033,592,00028,664,00026,102,00022,186,00022,661,00017,737,00016,837,00023,183,00020,764,00023,003,00022,395,00019,640,000
  S&GA Expenses-21.5%28,941,00036,880,00039,962,00037,027,00031,706,00034,846,00031,268,00032,957,00026,913,00027,558,00024,780,00021,753,00018,138,00018,195,00015,008,00014,438,00018,984,00017,134,00019,227,00018,394,00016,056,000
  R&D Expenses-26.6%4,273,0005,820,0007,128,0006,947,0006,533,0006,479,0005,289,0004,903,0003,598,0006,034,0003,884,0004,349,0004,048,0004,466,0002,729,0002,399,0004,199,0003,630,0003,776,0004,001,0003,584,000
EBITDA Margin-12.8%-0.43-0.38-0.31-0.25-0.38-0.38-0.40-0.42-0.22-0.24-0.20-0.11---------
Interest Expenses1.0%4,381,0004,338,0003,679,0003,620,0003,756,0002,200,0003,880,0003,388,0002,292,0002,326,0002,293,0002,248,0002,195,0002,211,0002,886,0002,130,0002,146,0002,128,0001,805,0002,521,0002,242,000
Income Taxes117.5%438,000-2,505,000669,000925,000830,000819,000603,000564,000399,000788,00066,000408,000165,000-502,000181,000194,000231,000253,000308,00035,00044,000
Earnings Before Taxes31.6%-15,764,000-23,047,000-28,604,000-15,820,000-11,112,000-12,743,000-18,005,000-36,542,000-5,534,000-13,403,000-14,612,000-4,914,000-6,783,000-6,153,000-4,064,000-10,278,000-17,522,000-5,303,000-12,467,000-9,005,000-10,735,000
EBT Margin-12.3%-0.53-0.48-0.38-0.33-0.46-0.45-0.48-0.49-0.29-0.31-0.27-0.20---------
Net Income21.1%-16,202,000-20,542,000-29,273,000-16,745,000-11,942,000-13,562,000-18,608,000-37,106,000-5,933,000-14,191,000-14,678,000-5,322,000-6,948,000-5,651,000-4,245,000-10,472,000-17,753,000-5,556,000-12,775,000-9,040,000-10,779,000
Net Income Margin-11.8%-0.53-0.48-0.40-0.34-0.48-0.47-0.50-0.50-0.30-0.32-0.28-0.20---------
Free Cashflow-64.3%-14,464,000-8,803,000-35,215,000-31,357,000-21,046,000-14,982,000-22,460,000-11,937,000-5,638,000-7,467,000-13,418,000-1,714,000---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets12.4%302269271285209211188200142140148152152156155157168117118105109
  Current Assets16.5%20417518720914215013815611011312512812813213413614896.0098.0084.0092.00
    Cash Equivalents82.3%73.0040.0052.0090.0043.0066.0065.0091.0045.0053.0065.0077.0078.0085.0081.0086.0094.0038.0043.0032.0043.00
  Inventory-8.8%72.0079.0068.0056.0046.0037.0032.0027.0029.0028.0027.0024.0022.0023.0028.0029.0026.0029.0026.0027.0024.00
  Net PPE2.6%79.0077.0073.0066.0057.0051.0039.0035.0023.0019.0017.0017.0016.0016.0016.0016.0016.0016.0017.0017.0013.00
  Goodwill0%0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Liabilities-2.1%24525024023022521918618494.0089.0087.0083.0080.0081.0075.0075.0078.0077.0074.0051.0048.00
  Current Liabilities-16.0%48.0057.0050.0043.0041.0039.0032.0035.0037.0032.0030.0027.0025.0026.0020.0021.0022.0023.0020.0021.0017.00
  Long Term Debt1.8%192189185182179175148-52.00-51.0051.0050.0050.0049.0049.00-48.00---
    LT Debt, Non Current1.8%192189185182179175148-52.00-51.0051.0050.0050.0049.0049.00-48.00---
Shareholder's Equity209.4%57.0018.0030.0055.00-16.00-8.182.0016.0048.0051.0062.0069.0073.0075.0080.0082.0090.0040.0044.0054.0061.00
  Retained Earnings-4.5%-376-360-339-310-293-281-268-249-212-206-192-177-172-165-159-155-144-127-121-108-99.75
  Additional Paid-In Capital4.9%67.0064.0060.0056.0053.0050.0047.0044.0040.0037.0034.0031.0028.0027.0026.0024.0023.0021.0020.0019.0017.00
Accumulated Depreciation5.5%17.0016.00-----------------6.006.00
Shares Outstanding5.3%27.0026.0026.0026.0025.0024.0024.0024.0024.0024.0024.0024.00---------
Float----1,342---977---1,522---317---300-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-36.9%-11,152-8,148-31,511-28,240-20,614-14,016-21,980-11,330-4,840-7,709-12,455-814-6,5543,434-3,047-6,095-6,802-4,026-10,896-7,063-7,998
  Share Based Compensation-0.2%3,4443,4513,9713,6163,3243,2602,9213,7433,4343,0303,0642,5571,756-1,3481,5571,629----
Cashflow From Investing-43.4%-6,626-4,620-6,600-9,049-4,278-10,428-4,810-13,814-5,739-3,615-1,083-933-1,532-1,124-2,153-1,333-949-1,359-741-4,211-1,455
Cashflow From Financing78427.7%51,04365.0048784,4921,18324,9771,26572,3181,6952071,6374221,78653890.0011663,92636522,466-26.00-16.00
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

ESTA Income Statement

2024-03-31
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
Revenue$ 37,167$ 46,524
Cost of revenue12,78716,445
Gross profit24,38030,079
Operating expenses:  
Sales, general and administrative28,94131,706
Research and development4,2736,533
Total operating expenses33,21438,239
Loss from operations(8,834)(8,160)
Interest income48875
Interest expense(4,381)(3,756)
Other income (expense), net(3,037)729
Loss before income taxes(15,764)(11,112)
Provision for income taxes(438)(830)
Net loss$ (16,202)$ (11,942)
Basic net loss per share (in dollars per share)$ (0.58)$ (0.48)
Diluted net loss per share (in dollars per share)$ (0.58)$ (0.48)
Weighted average outstanding shares used for basic net loss per share (in shares)27,788,12024,678,113
Weighted average outstanding shares used for diluted net loss per share (in shares)27,788,12024,678,113

ESTA Balance Sheet

2024-03-31
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash$ 72,980$ 40,035
Accounts receivable, net of allowance for credit losses of $2,014 and $1,84150,83846,918
Inventory, net72,48979,471
Prepaid expenses and other current assets7,3888,477
Total current assets203,695174,901
Long-term assets:  
Property and equipment, net of accumulated depreciation79,24477,205
Goodwill465465
Intangible assets, net of accumulated amortization9,5157,987
Right-of-use operating lease assets, net3,9083,381
Other non-current assets5,0114,702
Total assets301,838268,641
Current liabilities:  
Accounts payable31,07041,624
Accrued liabilities15,20713,690
Other liabilities, short-term1,7391,836
Total current liabilities48,01657,150
Long-term liabilities:  
Note payable, net of debt discount and issuance costs192,186188,739
Operating lease liabilities, non-current3,1802,712
Other liabilities, long-term1,5451,645
Total liabilities244,927250,246
Commitments and contingencies (Note 13)
Shareholders’ equity:  
Common shares — zero par value, unlimited amount authorized; $27,884,749 and $26,495,250 shares issued at March 31, 2024 and December 31, 2023, respectively; $27,476,679 and $26,087,180 shares outstanding at March 31, 2024 and December 31, 2023, respectively367,138315,634
Additional paid-in-capital66,84163,748
Treasury shares, at cost, 408,070 shares held at March 31, 2024 and December 31, 2023(2,854)(2,854)
Accumulated deficit(376,298)(360,096)
Accumulated other comprehensive income2,0841,963
Total shareholders’ equity56,91118,395
Total liabilities and shareholders’ equity$ 301,838$ 268,641
ESTA
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
 CEO
 WEBSITEestablishmentlabs.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES958

Establishment Labs Holdings Inc Frequently Asked Questions


What is the ticker symbol for Establishment Labs Holdings Inc? What does ESTA stand for in stocks?

ESTA is the stock ticker symbol of Establishment Labs Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Establishment Labs Holdings Inc (ESTA)?

As of Tue Jun 18 2024, market cap of Establishment Labs Holdings Inc is 1.2 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ESTA stock?

You can check ESTA's fair value in chart for subscribers.

What is the fair value of ESTA stock?

You can check ESTA's fair value in chart for subscribers. The fair value of Establishment Labs Holdings Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Establishment Labs Holdings Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ESTA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Establishment Labs Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether ESTA is over valued or under valued. Whether Establishment Labs Holdings Inc is cheap or expensive depends on the assumptions which impact Establishment Labs Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ESTA.

What is Establishment Labs Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Jun 18 2024, ESTA's PE ratio (Price to Earnings) is -14.46 and Price to Sales (PS) ratio is 7.68. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ESTA PE ratio will change depending on the future growth rate expectations of investors.